(Q50770547)

18 March 2018

title

Involvement of cholinergic receptors in the different stages of memory measured in the modified elevated plus maze test in mice (English)

1 reference

18 March 2018

1 reference

2

Barbara Budzyńska

1 reference

18 March 2018

Grażyna Biała

series ordinal

3

object named as

Grażyna Biała

1 reference

18 March 2018

author name string

Marta Kruk-Słomka

series ordinal

1

1 reference

18 March 2018

publication date

1 January 2012

1 reference

18 March 2018

published in

Pharmacological Reports

1 reference

18 March 2018

volume

64

1 reference

18 March 2018

issue

5

1 reference

18 March 2018

page(s)

1066-1080

1 reference

18 March 2018

Nicotinic mechanisms of memory: effects of acute local DHbetaE and MLA infusions in the basolateral amygdala

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Ventral hippocampal alpha4beta2 nicotinic receptors and chronic nicotine effects on memory

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Ventral hippocampal alpha 7 nicotinic receptor blockade and chronic nicotine effects on memory performance in the radial-arm maze

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Cannabinoid receptor ligands suppress memory-related effects of nicotine in the elevated plus maze test in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Influence of bupropion and calcium channel antagonists on the nicotine-induced memory-related response of mice in the elevated plus maze.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Varenicline and mecamylamine attenuate locomotor sensitization and cross-sensitization induced by nicotine and morphine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Mecamylamine blocks enhancement of reference memory but not working memory produced by post-training injection of nicotine in rats tested on the radial arm maze

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Acetylcholine: a neurotransmitter for learning and memory?

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Neuronal nicotinic receptor subtypes: defining therapeutic targets

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Improvement in performance of a delayed matching-to-sample task by monkeys following ABT-418: a novel cholinergic channel activator for memory enhancement

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of scopolamine on locomotor activity and metabolic rate in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of risperidone on learning and memory in naive and MK-801-treated rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic receptors at the amino acid level

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The nicotinic acetylcholine receptor partial agonist varenicline and the treatment of drug dependence: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Adenosine A2A receptor blockade prevents memory dysfunction caused by beta-amyloid peptides but not by scopolamine or MK-801.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Hippocampal alpha4beta2 nicotinic acetylcholine receptor involvement in the enhancing effect of acute nicotine on contextual fear conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The cholinergic system and spatial learning

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The septohippocampal pathway: structure and function of a central cholinergic system

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Scopolamine model of dementia: electroencephalogram findings and cognitive performance.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Smoking cessation pharmacotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of prolonged nicotinic ligand exposure on function of heterologously expressed, human alpha4beta2- and alpha4beta4-nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Differential effects of scopolamine and mecamylamine on passive avoidance behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effect of subtype selective nicotinic compounds on attention as assessed by the five-choice serial reaction time task.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The role of acetylcholine in learning and memory

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of nicotine on memory impairment induced by blockade of muscarinic, nicotinic and dopamine D2 receptors in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Improvement by low doses of nociceptin on scopolamine-induced impairment of learning and/or memory.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Reversion of muscarinic autoreceptor agonist-induced acetylcholine decrease and learning impairment by dynorphin A (1-13), an endogenous kappa-opioid receptor agonist

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Partial agonists as therapeutic agents at neuronal nicotinic acetylcholine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Cognitive enhancement by drugs in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Utility of an elevated plus-maze for the evaluation of memory in mice: effects of nootropics, scopolamine and electroconvulsive shock

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Utility of an elevated plus-maze for dissociation of amnesic and behavioral effects of drugs in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Pharmacotherapy for tobacco cessation: nicotine agonists, antagonists, and partial agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Pharmacotheraphy for Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic systems and cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Hippocampal alpha 7 and alpha 4 beta 2 nicotinic receptors and working memory

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of the nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic alpha7- or beta2-containing receptor knockout: effects on radial-arm maze learning and long-term nicotine consumption in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic treatment for cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic interactions with antipsychotic drugs, models of schizophrenia and impacts on cognitive function

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotinic acetylcholine involvement in cognitive function in animals

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The use of a plus-maze to measure anxiety in the mouse

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

alpha7 and non-alpha7 nicotinic acetylcholine receptors modulate dopamine release in vitro and in vivo in the rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Deletion of the alpha7, beta2, or beta4 nicotinic receptor subunit genes identifies highly expressed subtypes with relatively low affinity for [3H]epibatidine

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The role of nicotinic receptors in the amelioration of cholinesterase inhibitors in scopolamine-induced memory deficits.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Varenicline is a partial agonist at alpha4beta2 and a full agonist at alpha7 neuronal nicotinic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

The role of nicotinic and muscarinic acetylcholine receptors in attention.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Ameliorating effects of histidine on scopolamine-induced learning deficits using an elevated plus-maze test in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Scopolamine deficits in negative patterning discrimination: evidence for a role of the central cholinergic system in retention but not acquisition of non-spatial configural association learning

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Varenicline improves mood and cognition during smoking abstinence

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Neuronal nicotinic acetylcholine receptor subunit knockout mice: physiological and behavioral phenotypes and possible clinical implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of molsidomine on scopolamine-induced amnesia and hypermotility in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Nicotine improves memory in an object recognition task in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effects of nicotine and mecamylamine on choice accuracy in an operant visual signal detection task in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

A postmortem study of brain nicotinic receptors in Parkinson's and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Rationale, pharmacology and clinical efficacy of partial agonists of alpha4beta2 nACh receptors for smoking cessation

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Scopolamine reduces persistent activity related to long-term encoding in the parahippocampal gyrus during delayed matching in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

L-histidine provokes a state-dependent memory retrieval deficit in mice re-exposed to the elevated plus-maze

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Evaluation of learning and memory mechanisms employing elevated plus-maze in rats and mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Cognitive performance and cholinergic transmission: influence of muscarinic and nicotinic receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

A comparison of the effects of nicotine on dopamine and non-dopamine neurons in the rat ventral tegmental area: an in vitro electrophysiological study

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

Impaired attention is central to the cognitive deficits observed in alpha 7 deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS1734-1140%2812%2970904-0

7 January 2021

10.1016/S1734-1140(12)70904-0

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018